IL-6 type cytokine receptor complexes: Hexamer, tetramer or both?

Biological Chemistry

Volumn 380, Issue 7-8, 1999, Pages 803-813

  Grötzinger, Joachim ^a   Kernebeck, Thomas ^a   Kallen, Karl Josef ^b   Rose John, Stefan ^b  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^b JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

CNTF; Cytokine; IL 6; Receptor complex

Indexed keywords

CILIARY NEUROTROPHIC FACTOR; CYTOKINE RECEPTOR; IMMUNOGLOBULIN; INTERLEUKIN 6 RECEPTOR; RECEPTOR SUBUNIT; TETRAMER;

ANIMAL CELL; COMPLEX FORMATION; CRYSTAL STRUCTURE; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN FOLDING; REVIEW; STOICHIOMETRY;

BIOPOLYMERS; CILIARY NEUROTROPHIC FACTOR; FIBRONECTINS; INTERLEUKIN-6; MODELS, MOLECULAR; NERVE TISSUE PROTEINS; RECEPTORS, CYTOKINE;

ANIMALIA;

EID: 0038642195     PISSN: 14316730     EISSN: None     Source Type: Journal    
DOI: 10.1515/BC.1999.100     Document Type: Review

References (77)

1. Auguste, P., Guillet, C., Fourcin, M., Olivier, C., Veziers, J., Pouplard Barthelaix, A., and Gascan, H. (1997). Signaling of type II oncostatin M receptor. J. Biol. Chem. 272, 15760-15764.
2. Barton, V.A., Hudson, K.R., and Heath, J.K. (1999). Identification of three distinct receptor binding sites of murine interleukin-11. J. Biol. Chem. 274, 5755-5761.
3. Bazan, J.F. (1990a). Haemopoietic receptors and helical cytokines. Immunol. Today 11, 350-354.
4. Bazan, J.F. (1990b). Structural design and molecular evolution of a cytokine receptor superfamily. Proc. Natl. Acad. Sci. USA 87, 6934-6938.
5. Bazan, J.F. (1991). Neuropoietic cytokines in the hematopoietic fold. Neuron 7, 197-208.
6. Brandhuber, B.J., Boone, T., Kenney, W.C., and McKay, D.B. (1987). Three-dimensional structure of interleukin-2. Science 238, 1707-1709.
7. Bravo, J., Staunton, D., Heath, J.K., and Jones, E.Y. (1998). Crystal structure of a cytokine-binding region of gp130. EMBO J. 17, 1665-1674.
8. Cheetham, J.C., Smith, D.M., Aoki, K.H., Stevenson, J.L., Hoeffel, T.J., Syed, R.S., Egrie, J., and Harvey, T.S. (1998). NMR structure of human erythropoietin and a comparison with its receptor bound conformation. Nat. Struct. Biol. 5, 861-866.
9. Clackson, T., and Wells, J.A. (1995). A hot spot of binding energy in a hormone-receptor interface. Science 267, 383-386.
10. Curtis, D.J., Hilton, D.J., Roberts, B., Murray, L., Nicola, N., and Begley, C.G. (1997). Recombinant soluble interleukin-11 (IL-11) receptor alpha-chain can act as an IL-11 antagonist. Blood 90, 4403-4412.
11. de Hon, F.D., Ehlers, M., Rose-John, S., Ebeling, S.B., Bos, H.K., Aarden, L.A., and Brakenhoff, J.P. (1994). Development of an interleukin (IL) 6 receptor antagonist that inhibits IL-6-dependent growth of human myeloma cells. J. Exp. Med. 180, 2395-2400.
12. de Hon, F.D., ten Boekel, E., Herrman, J., Clement, C., Ehlers, M., Taga, T., Yasukawa, K., Ohsugi, Y., Kishimoto, T., Rose-John, S., Wijdenes, J., Kastelein, R., Aarden, L.A., and Brakenhoff, J.P.J. (1995). Functional distinction of two regions of human interleukin 6 important for signal transduction via gp130. Cytokine 7, 398-407.
13. De Meyts, P. (1994). The structural basis of insulin and insulin-like growth factor-I receptor binding and negative co-operativity, and its relevance to mitogenic versus metabolic signalling. Diabetologia 37, 135-148.
14. De Serio, A., Graziani, R., Laufer, R., Ciliberto, G., and Paonessa, G. (1995). In vitro binding of ciliary neurotrophic factor to its receptors: evidence for the formation of an IL-6-type hexameric complex. J. Mol. Biol. 254, 795-800.
15. De Vos, A.M., Ultsch, M., and Kossiakoff, A.A. (1992). Human growth hormone and extracellular domain of its receptor: crystal structure of the complex. Science 255, 306-312.
16. Ehlers, M., Grötzinger, J., deHon, F.D., Müllberg, J., Brakenhoff, J.P., Liu, J., Wollmer, A., and Rose-John, S. (1994). Identification of two novel regions of human IL-6 responsible for receptor binding and signal transduction. J. Immunol. 153, 1744-1753.
17. Feng, Y., Klein, B.K., and McWherter, C.A. (1996). Three-dimensional solution structure and backbone dynamics of a variant of human interleukin-3. J. Mol. Biol. 259, 524-541.
18. Grötzinger, J., Kurapkat, G., Wollmer, A., Kalai, M., and Rose-John, S. (1997). The family of the IL-6-type cytokines: Specificity and promiscuity of the receptor complexes. Proteins: Structure, Function, and Genetics 27, 96-109.
19. Grube, B.J., and Cochrane, C.G. (1994). Identification of a regulatory domain of the interleukin-6 receptor. J. Biol. Chem. 269, 20791-20797.
20. Hage, T., Sebald, W., and Reinemer, P. (1999). Crystal structure of the interleukin-4/receptor chain complex reveals a mosaic binding interface. Cell 97, 271-281.
21. Hammacher, A., Richardson, R.T., Layton, J.E., Smith, D.K., Angus, L.J., Hilton, D.J., Nicola, N.A., Wijdenes, J., and Simpson, R.J. (1998). The immunoglobulin-like module of gp130 is required for signaling by interleukin-6, but not by leukemia inhibitory factor. J. Biol. Chem. 273, 22701-22707.
22. Heinrich, P.C., Behrmann, I., Muller Newen, G., Schaper, F., and Graeve, L. (1998). Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway. Biochem. J. 334, 297-314.
23. Hill, C.P., Osslund, T.D., and Eisenberg, D. (1993). The structure of granulocyte-colony-stimulating factor and its relationship to other growth factors. Proc. Natl. Acad. Sci. USA 90, 5167-5171.
24. Horsten, U. (1997). Identifizierung einer Region im Signaltransduktor gp130 für die Interaktion mit Interleukin-6 (IL-6) im ternären IL-6/IL-6-Rezeptor/gp130-Komplex. Dissertation, RWTH-Aachen, Germany.
25. Horsten, U., Schmitz-Van de Leur, H., Müllberg, J., Heinrich, P.C., and Rose-John, S. (1995). The membrane distal half of gp130 is responsible for the formation of a ternary complex with IL-6 and the IL-6 receptor. FEBS Lett. 360, 43-46.
26. Horsten, U., Muller Newen, G., Gerhartz, C., Wollmer, A., Wijdenes, J., Heinrich, P.C., and Grötzinger, J. (1997). Molecular modeling-guided mutagenesis of the extracellular part of gp130 leads to the identification of contact sites in the interleukin-6 (IL-6).IL-6 receptor.gp130 complex. J. Biol. Chem. 272, 23748-23757.
27. Hudson, K.R., Vernallis, A.B., and Heath, J.K. (1996). Characterization of the receptor binding sites of human leukemia inhibitory factor and creation of antagonists. J. Biol. Chem. 271, 11971-11978.
28. Kalai, M., Montero-Julian, F.A., Grötzinger, J., Wollmer, A., Morelle, D., Brochier, J., Rose-John, S., Heinrich, P.C., Brailly, H., and Content, J. (1996). Participation of two Ser-Ser-Phe-Tyr repeats in interleukin-6 (IL-6)- binding sites of the human IL-6 receptor. Eur. J. Biochem. 238, 714-723.
29. Kalai, M., Montero Julian, F.A., Brakenhoff, J.P., Fontaine, V., De Wit, L., Wollmer, A., Brailly, H., Content, J., and Grötzinger, J. (1997a). Analysis of the mechanism of action of anti-human interleukin-6 and anti-human interleukin-6 receptor-neutralising monoclonal antibodies. Eur. J. Biochem. 249, 690-700.
30. Kalai, M., Montero Julian, F.A., Grötzinger, J., Fontaine, V., Vandenbussche, P., Deschuyteneer, R., Wollmer, A., Brailly, H., and Content, J. (1997b). Analysis of the human interleukin-6/-human interleukin-6 receptor binding interface at the amino acid level: proposed mechanism of interaction. Blood 89, 1319-1333.
31. Kallen, K.-J., Meyer zum Büschenfelde, K.H., and Rose-John, S. (1997). The therapeutic potential of interleukin-6 hyperagonists and antagonists. Exp. Opin. Invest. Drugs 6, 237-266.
32. Kallen, K.-J., Grötzinger, J., Lelièvre, E., Vollmer, P., Aasland, D., Renné, C., Müllberg, J., Meyer zum Büschenfelde, K.-H., Gascan, H., and Rose-John, S. (1999). Receptor recognition sites of cytokines are organized as exchangeable moduls: transfer of the LIFR binding site from CNTF to IL-6. J. Biol. Chem. 274, 11859-11867.
33. Kernebeck, T., Pflanz, S., Muller-Newen, G., Kurapkat, G., Scheek, R.M., Dijkstra, K., Heinrich, P.C., Wollmer, A., Grzesiek, S., and Grötzinger, J. (1999). The signal transducer gp130: solution structure of the carboxy-terminal domain of the cytokine receptor homology region. Protein Sci. 8, 5-12.
34. Kurth, I., Horsten, U., Pflanz, S., Dahmen, H., Kuster, A., Grötzinger, J., Heinrich, P.C., and Muller-Newen, G. (1999). Activation of the signal transducer glycoprotein 130 by both IL-6 and IL-11 requires two distinct binding epitopes. J. Immunol. 162, 1480-1487.
35. Livnah, O., Stura, E.A., Middleton, S.A., Johnson, D.L., Jolliffe, L.K., and Wilson, I.A. (1999). Crystallographic evidence for preformed dimers of erythropoietin receptor before ligand activation. Science 283, 987-990.
36. März, P., Otten, U., and Rose-John, S. (1999). Neuronal activities of IL-6 type cytokines often depend on soluble cytokine receptors. Eur. J. Neurosci., in press.
37. McDonald, N.Q., Panayotatos, N., and Hendrickson, W.A. (1995). Crystal structure of dimeric human ciliary neurotrophic factor determined by MAD phasing. EMBO J. 14, 2689-2699.
38. Milburn, M.V., Hassell, A.M., Lambert, M.H., Jordan, S.R., Proudfoot, A.E., Graber, P., and Wells, T.N. (1993). A novel dimer configuration revealed by the crystal structure at 2.4 A resolution of human interleukin-5. Nature 363, 172-176.
39. Mosley, B., De Imus, C., Friend, D., Boiani, N., Thoma, B., Park, L.S., and Cosman, D. (1996). Dual oncostatin M (OSM) receptors. Cloning and characterization of an alternative signaling subunit conferring OSM-specific receptor activation. J. Biol. Chem. 271, 32635-32643.
40. Müller-Newen, G., Küster, A., Hemmann, U., Keul, R., Horsten, U., Martens, A., Graeve, L., Wijdenes, J., and Heinrich, P.C. (1998). Soluble IL-6 receptor potentiates the antagonistic activity of soluble gp130 on IL-6 responses. J. Immunol. 161, 6347-6355.
41. Owczarek, C.M., Zhang, Y., Layton, M.J., Metcalf, D., Roberts, B., and Nicola, N.A. (1997). The unusual species cross-reactivity of the leukemia inhibitory factor receptor alpha-chain is determined primarily by the immunoglobulin-like domain. J. Biol. Chem. 272, 23976-23985.
42. Özbek, S., Grötzinger, J., Krebs, B., Fischer, M., Wollmer, A., Jostock, T., Müllberg, J., and Rose-John, S. (1998). The membrane proximal cytokine receptor domain of the human interleukin-6-receptor is sufficient for ligand binding but not for gp130 association. J. Biol. Chem. 273, 21374-21379.
43. Paonessa, G., Graziani, R., De Serio, A., Savino, R., Ciapponi, L., Lahm, A., Salvati, A.L., Toniatti, C., and Ciliberto, G. (1995). Two distinct and independent sites on IL-6 trigger gp 130 dimer formation and signalling. EMBO J. 14, 1942-1951.
44. Pennica, D., Arce, V., Swanson, T.A., Vejsada, R., Pollock, R.A., Armanini, M., Dudley, K., Phillips, H.S., Rosenthal, A., Kato, A.C., and Henderson, C.E. (1996). Cardiotrophin-1, acytokine present in embryonic muscle, supports long-term survival of spinal motoneurons. Neuron 17, 63-74.
45. Powers, R., Garrett, D.S., March, C. J., Frieden, E.A., Gronenborn, A.M., and Clore, G.M. (1992). Three-dimensional solution structure of human interleukin-4 by multidimensional heteronuclear magnetic resonance spectroscopy. Science 256, 1673-1677.
46. Reidhaar-Olson, J.F., De Souza-Hart, J.A., and Selick, H.E. (1996). Identification of residues critical to the activity of human granulocytecolony-stimulating factor. Biochemistry 35, 9034-9041.
47. Remy, I., Wilson, I.A., and Michnick, S.W. (1999). Erythropoietin receptor activation by a ligand-induced conformation change. Science 263, 990-993.
48. Robinson, R.C., Grey, L.M., Staunton, D., Vankelecom, H., Vernallis, A.B., Moreau, J.F., Stuart, D.I., Heath, J.K., and Jones, E.Y. (1994). The crystal structure and biological function of leukemia inhibitory factor: implications for receptor binding. Cell 77, 1101-1116.
49. Robledo, O., Fourcin, M., Chevalier, S., Guillet, C., Auguste, P., Pouplard Barthelaix, A., Pennica, D., and Gascan, H. (1997). Signaling of the cardiotrophin-1 receptor. Evidence for a third receptor component. J. Biol. Chem. 272, 4855-4863.
50. Rose-John, S., and Heinrich, P.C. (1994). Soluble receptors for cytokines and growth factors: generation and biological function. Biochem. J. 300, 281-290.
51. Rubinstein, M., Dinarello, C.A., Oppenheim, J.J., and Hertzog, P. (1998). Recent advances in cytokines, cytokine receptors and signal transduction. Cytokine Growth Factor Rev. 9, 175-181.
52. Savino, R., Ciapponi, L., Lahm, A., Demartis, A., Cabibbo, A., Toniatti, C., Delmastro, P., Altamura, S., and Ciliberto, G. (1994a). Rational design of a receptor super-antagonist of human interleukin-6. EMBO J. 13, 5863-5870.
53. Savino, R., Lahm, A., Salvati, A.L., Ciapponi, L., Sporeno, E., Altamura, S., Paonessa, G., Toniatti, C., and Ciliberto, G. (1994b). Generation of interleukin-6 receptor antagonists by molecular-modeling guided mutagenesis of residues important for gp130 activation. EMBO J. 13, 1357-1367.
54. Simpson, R.J., Hammacher, A., Smith, D.K., Matthews, J.M., and Ward, L.D. (1997). Interleukin-6: structure-function relationships. Protein Sci. 6, 929-955.
55. Somers, W., Ultsch, M., De Vos, A.M., and Kossiakoff, A.A. (1994). The X-ray structure of a growth hormone-prolactin receptor complex. Nature 372, 478-481.
56. Somers, W., Stahl, M., and Seehra, J.S. (1997). 1.9 Acrystal structure of interleukin 6: implications for a novel mode of receptor dimerization and signaling. EMBO J. 16, 989-997.
57. Sprang, S.R., and Bazan, J.F. (1993). Cytokine structural taxonomy and mechanism of receptor engagement. Curr. Opin. Struct. Biol. 3, 815-827.
58. Staunton, D., Hudson, K.R., and Heath, J.K. (1998). The interactions of the cytokine-binding homology region and immunoglobulin-like domains of gp130 with oncostatin M: implications for receptor complex formation. Protein Eng. 11, 1093-1102.
59. Syed, R.S., Reid, S.W., Li, C., Cheetham, J.C., Aoki, K.H., Liu, B., Zhan, H., Osslund, T.D., Chirino, A.J., Zhang, J., Finer-Moore, J., Elliott, S., Sitney, K., Katz, B.A., Matthews, D.J., Wendoloski, J.J., Egrie, J., and Stroud, R.M. (1998). Efficiency of signalling through cytokine receptors depends critically on receptor orientation. Nature 395, 511-516.
60. Taga, T., and Kishimoto, T. (1997). gp130 and the Interleukin-6 Family of Cytokines. Annu. Rev. Immunol. 15, 797-819.
61. Ultsch, M.H., Somers, W., Kossiakoff, A.A., and de Vos, A.M. (1994). The crystal structure of affinity-matured human growth hormone at 2 A resolution. J. Mol. Biol. 236, 286-299.
62. van Dam, M., Müllberg, J., Schooltink, H., Stoyan, T., Brakenhoff, J.P., Graeve, L., Heinrich, P.C., and Rose-John, S. (1993). Structure-function analysis of interleukin-6 utilizing human/ murine chimeric molecules. Involvement of two separate domains in receptor binding. J. Biol. Chem. 268, 15285-15290.
63. Vernalis, A.B., Hudson, K.R., and Heath, J.K. (1997). An antagonist for the leukemia inhibitory factor receptor inhibits leukemia inhibitory factor, cardiotrophin-1, ciliary neurotrophic factor, and oncostatin M. J. Biol. Chem. 272, 26947-26952.
64. Vollmer, P., Peters, M., Ehlers, M., Yagame, H., Matsuba, T., Kondo, M., Yasukawa, K., Büschenfelde, K.H., and Rose-John, S. (1996). Yeast expression of the cytokine receptor domain of the soluble interleukin-6 receptor. J. Immunol. Methods 199, 47-54.
65. Vollmer, P., Oppmann, B., Voltz, N., Fischer, M., and Rose-John, S. (1999). The immunoglobulin-like domain of the human IL-6 Receptor is important for protein Stability and processing. Eur. J. Biochem., in press.
66. Ward, L.D., Hewlett, G.J., Discolo, G., Yasukawa, K., Hammacher, A., Moritz, R.L., and Simpson, R.J. (1994). High affinity interleukin-6 receptor is a hexameric complex consisting of two molecules each of interleukin-6, interleukin-6 receptor, and gp-130. J. Biol. Chem. 269, 23286-23289.
67. Watowich, S.S., Liu, K.D., Xie, X., Lai, S.Y., Mikami, A., Longmore, G.D., and Goldsmith, M.A. (1999). Oligomerization and scaffolding functions of the erythropoietin receptor cytoplasmic tail. J. Biol. Chem. 274, 5415-5421.
68. Wells, J.A. (1996a). Binding inthegrowth hormone receptor complex. Proc. Natl. Acad. Sci. USA 93, 1-6.
69. Wells, J.A. (1996b). Hematopoietic Receptor Complexes. Annu. Rev. Biochem. 65, 609-634.
70. Wlodaver, A., Pavlovsky, A., and Gustchina, A. (1992). Crystal structure of human recombinant interleukin-4 at 2.25 A resolution. FEBS Lett. 309, 59-64.
71. Xu, G.Y., Yu, H.A., Hong, J., Stahl, M., McDonagh, T., Kay, L.E., and Cumming, D.A. (1997). Solution structure of recombinant human interleukin-6. J. Mol. Biol. 268, 468-481.
72. Yamasaki, K., Taga, T., Hirata, Y., Yawata, H., Kawanishi, Y., Seed, B., Taniguchi, T., Hirano, T., and Kishimoto, T. (1988). Cloning and expression of the human interleukin-6 (BSF-2/IFN beta 2) receptor. Science 241, 825-828.
73. Yamasaki, K., Naito, S., Anaguchi, H., Ohkubo, T., and Ota, Y. (1997). Solution structure of an extracellular domain containing the WSxWS motif of the granulocyte colony-stimulating factor receptor and its interaction with ligand. Nat. Struct. Biol. 4, 498-504.
74. Yawata, H., Yasukawa, K., Natsuka, S., Murakami, M., Yamasaki, K., Hibi, M., Taga, T., and Kishimoto, T. (1993). Structure-function analysis of human IL-6 receptor: dissociation of amino acid residues required for IL-6-binding and for IL-6 signal transduction through gp130. EMBO J. 12, 1705-1712.
75. Young, D.C., Zhan, H., Cheng, Q.L., Hou, J., and Matthews, D.J. (1997). Characterization of the receptor binding determinants of granulocyte colony stimulating factor. Protein Sci. 6, 1228-1236.
76. Zdanov, A., Schalk-Hihi, C., and Wlodawer, A. (1996). Crystal structure of human interleukin-10 at 1.6 A resolution and a model of a complex with its soluble receptor. Protein Sci. 5, 1955-1962.
77. Zohlnhöfer, D., Graeve, L., Rose-John, S., Schooltink, H., Dittrich, E., and Heinrich, P.C. (1992). The hepatic interleukin-6 receptor. Down-regulation of the interleukin-6 binding subunit (gp80) by its ligand. FEBS Lett. 306, 219-222.